title: Therapeutic recommendations for 2013: antiviral treatment for chronic hepatitis B.
authors.affiliation: Juszczyk@post.pl
authors.forename: Jacek
authors.initials: J
authors.lastname: Juszczyk
authors.forename: Anna
authors.initials: A
authors.lastname: Boroń-Kaczmarska
authors.forename: Janusz
authors.initials: J
authors.lastname: Cianciara
authors.forename: Robert
authors.initials: R
authors.lastname: Flisiak
authors.forename: Andrzej
authors.initials: A
authors.lastname: Gładysz
authors.forename: Waldemar
authors.initials: W
authors.lastname: Halota
authors.forename: Wiesław
authors.initials: W
authors.lastname: Kryczka
authors.forename: Piotr
authors.initials: P
authors.lastname: Małkowski
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Pawłowska
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Simon
mesh_terms: D017677:Age Distribution; D000998:Antiviral Agents / Q000627:therapeutic use*; D019468:Disease Management; D005062:European Union; D005260:Female; D017408:Guidelines as Topic; D006297:Health Services Accessibility / Q000458:organization & administration; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D019694:Hepatitis B, Chronic / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D008297:Male; D011044:Poland / Q000453:epidemiology; D010818:Practice Patterns, Physicians' / Q000458:organization & administration; D011320:Primary Health Care / Q000458:organization & administration*; D011322:Primary Prevention / Q000458:organization & administration*
chemical_list: D000998:Antiviral Agents; D017325:Hepatitis B Vaccines